New radiation combo aims to zap prostate cancer faster

NCT ID NCT05754580

Recruiting now Disease control Sponsor: University of Nebraska Source: ClinicalTrials.gov ↗

Summary

This study is testing a combination of two types of targeted radiation to treat men with higher-risk prostate cancer that is still confined to the prostate area. The goal is to see if giving these treatments together is effective at controlling the cancer and has acceptable side effects. Researchers will enroll 53 patients to measure safety, cancer control, and quality of life impacts like urinary and sexual function.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Nebraska Medical Center
RECRUITING

Omaha, Nebraska, 68198, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PROSTATIC CANCER